Through its collaboration with Variational AI, Rakovina Therapeutics utilized the Enki™ generative AI platform to identify novel small-molecule candidates predicted to meet a defined target product ...
Rakovina Therapeutics Inc. announced promising results from its AI-driven kt-5000AI drug discovery program at the AACR-NCI-EORTC International Conference. The company showcased novel ATR inhibitors ...
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
A team of researchers led by Xiaoguang Dong, assistant professor of mechanical and biomedical engineering at Vanderbilt ...
Angiotensin receptor-neprilysin inhibitors (ARNIs) represent a significant advancement in heart failure therapy, combining an ...
Android Central on MSN
Android XR: Everything you need to know
Android XR is the software that Samsung and other brands will use for XR headsets, AR glasses, and smart glasses. We'll ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback